AVULUX LIVE WEBINAR
A Utah optical invention just made FDA history
The first and only FDA-authorized lens for migraine light sensitivity was invented right here in Utah — and the doctor who co-invented it is joining us to explain how it works. The Avulux team will share how to offer it in your practice.
Wednesday, November 18, 20269:00 AM MT / 12:00 PM MT
Featuring
Dr. Bradley J. Katz, MD, PhD — neuro-ophthalmologist at the University of Utah's Moran Eye Center and co-inventor of Avulux technology.
Reserve your seat
Free live webinarYou'll be taken to the registration page.
Reserve your seatAlready signed up? Add it to your calendar
What you'll learn
- Why it works + Who it's for: the science behind Avulux's precision light filtering and patient identification
- Becoming a provider: how to get started, the support you'll get, and how current partners can grow with Avulux
- FDA Authorization: a quick look at our recent FDA authorization and how it supports your conversations with patients
- Live Q&A with Dr. Katz
Who it's for
- Optometrists and ophthalmologists who see patients with migraine light sensitivity
- Practice managers and optical teams deciding what to offer those patients
- Practices considering carrying Avulux®
Avulux is FDA-authorized to decrease the impact of light sensitivity in patients diagnosed with episodic migraine, ages 12 and older, alongside usual care.